Cargando…
LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the predominant histological type of primary liver cancer, which ranks sixth among the most common human tumors. Tumor-associated macrophages (TAMs) are an important component of tumor microenvironment (TME) and the M2 macrophage polarization substantial...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329916/ https://www.ncbi.nlm.nih.gov/pubmed/37435155 http://dx.doi.org/10.2147/JHC.S408800 |
_version_ | 1785070118240256000 |
---|---|
author | Wei, Qing Liu, Guoman Huang, Zihua Huang, Yanyan Huang, Lizheng Huang, Zheng Wu, Xianjian Wei, Huamei Pu, Jian |
author_facet | Wei, Qing Liu, Guoman Huang, Zihua Huang, Yanyan Huang, Lizheng Huang, Zheng Wu, Xianjian Wei, Huamei Pu, Jian |
author_sort | Wei, Qing |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) is the predominant histological type of primary liver cancer, which ranks sixth among the most common human tumors. Tumor-associated macrophages (TAMs) are an important component of tumor microenvironment (TME) and the M2 macrophage polarization substantially contributes to tumor growth and metastasis. Long non-coding RNA (lncRNA) MEG3 was reported to restrain HCC development. However, whether MEG3 regulates macrophage phenotypic polarization in HCC remains unclear. METHODS: Bone marrow derived macrophages (BMDMs) were treated with LPS/IFNγ and IL4/IL13 to induce the M1 and M2 macrophage polarization, respectively. M2-polarized BMDMs were simultaneously transfected with adenovirus vector overexpressing MEG3 (Adv-MEG3). Subsequently, M2-polarized BMDMs were cultured for 24 h with serum-free medium, the supernatants of which were harvested as conditioned medium (CM). HCC cell line Huh7 was cultured with CM for 24 h. F4/80(+)CD68(+) and F4/80(+)CD206(+) cell percentages in M1-and M2-polarized BMDMs were calculated using flow cytometry. Huh7 cell migration, invasion and angiogenesis were determined via Transwell assay and tube formation experiment. Nude mice were implanted with Huh7 cells and Adv-MEG3-transfected M2-polarizd BMDMs, and tumor growth and M2 macrophage polarization markers were assessed. The binding between miR-145-5p and MEG3 or disabled-2 (DAB2) was verified by luciferase reporter assay. RESULTS: MEG3 presented lower expression in HCC tissues than in normal controls, and low expression of MEG3 was correlated to poorer prognosis of HCC patients. MEG3 expression was enhanced during LPS/IFNγ-induced M1 polarization, but was reduced during IL4/IL13-induced M2 polarization. MEG3 overexpression inhibited the expression of M2 polarization markers in both M2-polarized BMDMs and mice. Mechanically, MEG3 bound with miR-145-5p to regulate DAB2 expression. Overexpressing MEG3 suppressed M2 polarization-induced HCC cell metastasis and angiogenesis by upregulating DAB2 and inhibited in vivo tumor growth. CONCLUSION: LncRNA MEG3 curbs HCC development by repressing M2 macrophage polarization via miR-145-5p/DAB2 axis. |
format | Online Article Text |
id | pubmed-10329916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103299162023-07-11 LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma Wei, Qing Liu, Guoman Huang, Zihua Huang, Yanyan Huang, Lizheng Huang, Zheng Wu, Xianjian Wei, Huamei Pu, Jian J Hepatocell Carcinoma Original Research BACKGROUND: Hepatocellular carcinoma (HCC) is the predominant histological type of primary liver cancer, which ranks sixth among the most common human tumors. Tumor-associated macrophages (TAMs) are an important component of tumor microenvironment (TME) and the M2 macrophage polarization substantially contributes to tumor growth and metastasis. Long non-coding RNA (lncRNA) MEG3 was reported to restrain HCC development. However, whether MEG3 regulates macrophage phenotypic polarization in HCC remains unclear. METHODS: Bone marrow derived macrophages (BMDMs) were treated with LPS/IFNγ and IL4/IL13 to induce the M1 and M2 macrophage polarization, respectively. M2-polarized BMDMs were simultaneously transfected with adenovirus vector overexpressing MEG3 (Adv-MEG3). Subsequently, M2-polarized BMDMs were cultured for 24 h with serum-free medium, the supernatants of which were harvested as conditioned medium (CM). HCC cell line Huh7 was cultured with CM for 24 h. F4/80(+)CD68(+) and F4/80(+)CD206(+) cell percentages in M1-and M2-polarized BMDMs were calculated using flow cytometry. Huh7 cell migration, invasion and angiogenesis were determined via Transwell assay and tube formation experiment. Nude mice were implanted with Huh7 cells and Adv-MEG3-transfected M2-polarizd BMDMs, and tumor growth and M2 macrophage polarization markers were assessed. The binding between miR-145-5p and MEG3 or disabled-2 (DAB2) was verified by luciferase reporter assay. RESULTS: MEG3 presented lower expression in HCC tissues than in normal controls, and low expression of MEG3 was correlated to poorer prognosis of HCC patients. MEG3 expression was enhanced during LPS/IFNγ-induced M1 polarization, but was reduced during IL4/IL13-induced M2 polarization. MEG3 overexpression inhibited the expression of M2 polarization markers in both M2-polarized BMDMs and mice. Mechanically, MEG3 bound with miR-145-5p to regulate DAB2 expression. Overexpressing MEG3 suppressed M2 polarization-induced HCC cell metastasis and angiogenesis by upregulating DAB2 and inhibited in vivo tumor growth. CONCLUSION: LncRNA MEG3 curbs HCC development by repressing M2 macrophage polarization via miR-145-5p/DAB2 axis. Dove 2023-07-05 /pmc/articles/PMC10329916/ /pubmed/37435155 http://dx.doi.org/10.2147/JHC.S408800 Text en © 2023 Wei et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wei, Qing Liu, Guoman Huang, Zihua Huang, Yanyan Huang, Lizheng Huang, Zheng Wu, Xianjian Wei, Huamei Pu, Jian LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title | LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title_full | LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title_fullStr | LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title_full_unstemmed | LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title_short | LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma |
title_sort | lncrna meg3 inhibits tumor progression by modulating macrophage phenotypic polarization via mir-145-5p/dab2 axis in hepatocellular carcinoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329916/ https://www.ncbi.nlm.nih.gov/pubmed/37435155 http://dx.doi.org/10.2147/JHC.S408800 |
work_keys_str_mv | AT weiqing lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT liuguoman lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT huangzihua lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT huangyanyan lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT huanglizheng lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT huangzheng lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT wuxianjian lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT weihuamei lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma AT pujian lncrnameg3inhibitstumorprogressionbymodulatingmacrophagephenotypicpolarizationviamir1455pdab2axisinhepatocellularcarcinoma |